Sanofi ADS stock is trading -20.17% below its average target price of $61.5 after dropping -1.2% during today's afternoon session. Analysts are giving the Large-Cap Pharmaceutical company an average rating of buy and target prices ranging from $53.0 to $69.0 per share.
The stock has a very low short interest at 0.2%, and a short ratio of 1.78. At 0.0%, the company's rate of insider ownership does not indicate that management is heavily invested in the corporation. Finally, we also note that a very small number of institutional investors are invested in the stock, with 10.3% of Sanofi ADS's shares being owned by this investor type.
Institutions Invested in Sanofi ADS
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2025-06-30 | Dodge & Cox Inc | 27% | 71,718,315 | $3,521,010,762 |
| 2025-06-30 | Fisher Asset Management, LLC | 5% | 13,135,366 | $644,880,809 |
| 2025-06-30 | Bank of America Corporation | 4% | 9,998,529 | $490,877,793 |
| 2025-06-30 | Invesco Ltd. | 3% | 9,188,204 | $451,094,886 |
| 2025-06-30 | Capital World Investors | 3% | 8,354,084 | $410,143,764 |
| 2025-06-30 | Morgan Stanley | 3% | 8,257,646 | $405,409,140 |
| 2025-06-30 | Barrow, Hanley Mewhinney & Strauss, LLC | 3% | 7,280,536 | $357,437,923 |
| 2025-06-30 | Raymond James Financial, Inc. | 2% | 5,879,894 | $288,673,403 |
| 2025-06-30 | Price (T.Rowe) Associates Inc | 2% | 5,525,745 | $271,286,457 |
| 2025-06-30 | Blackrock Inc. | 2% | 5,469,430 | $268,521,672 |
Besides an analyst consensus of strong upside potential, other market factors point to there being mixed market sentiment on Sanofi ADS.
